Skip to main content
OpenTrials
Completed

NCT Number: NCT05583695

Mindfulness-based Music Therapy in Blind Elderly Women

This trial aims to examine effects of mindfulness-based music therapy on mood regulation in blind elderly women.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Mindfulness Blind Elderly Mood Music Therapy

Age range

65 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Hong Kong Society for the Blind

Kowloon, Hong Kong

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • female
  • blind with visual acuity (the best eye) of 20/400 or below
  • aged 65 years or above
  • cognitive intact, measured using Hong Kong Montreal Cognitive Assessment (6th version) with a score ≥ 12
  • able to speak Cantonese

Exclusion criteria

  • none

Treatment and study plan

mindfulness-based music therapy

Behavioral

eight weekly sessions with a combination of both mindfulness and music therapy

Mindfulness-Based Therapy

Behavioral

eight weekly sessions of mindfulness

Routine Care

Behavioral

eight weekly sessions of routine care

Primary outcomes

  1. Difficulties in Emotion Regulation Scale (DERS)

    Time frame: at baseline

    Difficulties in Emotion Regulation Scale is a 36-item measure assessing six emotion regulation dimensions: non-acceptance, goals, impulse, strategies, clarity, and awareness. The total score ranges from 36 to 180. Higher scores represent more difficultly in regulating emotions.

  2. Difficulties in Emotion Regulation Scale (DERS)

    Time frame: In the 8th week from baseline

    Difficulties in Emotion Regulation Scale is a 36-item measure assessing six emotion regulation dimensions: non-acceptance, goals, impulse, strategies, clarity, and awareness. The total score ranges from 36 to 180. Higher scores represent more difficultly in regulating emotions.

Secondary outcomes

  1. Depression Anxiety Stress Scales-21 (DASS-21)

    Time frame: at baseline

    Depression Anxiety Stress Scales-21 is a 21-item scale designed to assess depression, anxiety, and stress symptoms. It is divided into three subscales with each containing 7 items. Each subscale total score ranges from 0 to 21. Higher scores indicate more severe symptoms.

  2. Depression Anxiety Stress Scales-21 (DASS-21)

    Time frame: In the 8th week from baseline

    Depression Anxiety Stress Scales-21 is a 21-item scale designed to assess depression, anxiety, and stress symptoms. It is divided into three subscales with each containing 7 items. Each subscale total score ranges from 0 to 21. Higher scores indicate more severe symptoms.

  3. Geriatric Depression Scale (GDS)

    Time frame: at baseline

    Geriatric Depression Scale is a 30-item questionnaire asking how participants felt over the past week. The total score ranges from 0 to 30. Higher scores indicate more depressive symptoms.

  4. Geriatric Depression Scale (GDS)

    Time frame: In the 8th week from baseline

    Geriatric Depression Scale is a 30-item questionnaire asking how participants felt over the past week. The total score ranges from 0 to 30. Higher scores indicate more depressive symptoms.

Sponsors and collaborators

Lead sponsor

The Hong Kong Polytechnic University

Other

Registry information

Official study title

Effects of Mindfulness-based Music Therapy on Emotional Regulation in Blind Elderly Women

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Oct 18, 2022
Registry last updated
Jun 26, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.